Ken Cohen, MD, FACP, discusses how new cognitive assessment tools are improving Alzheimer disease diagnosis.

Fibrosis occurs when inflammation activates immune cells and fibroblasts to release collagen and cytokines that remodel and ...

Elinzanetant 120 mg consistently reduced daily VMS frequency and severity and improved sleep quality from baseline to week 12, with greater mean changes compared with placebo across all studies. These ...

Early and lifelong trauma can intensify menopause symptoms and accelerate cardiovascular and brain aging, according to research. Trauma is common yet underrecognized and undertreated, and it can ...

Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.

Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

“The results of our analysis showed that overall, patients with SCLC who survived to receive 3L treatment are a select group with exceptionally long 1L OS of 24.5 versus 14.9 months for ...

AMCP Nexus 2025 will focus on drug pricing, access, and reimbursement, influenced by the Inflation Reduction Act and One Big ...

Craig See, MD, a cornea specialist for the Cole Eye Institute at Cleveland Clinic, emphasized that cornea injuries are ...

The FDA has approved revumenib (Revuforj; Syndax Pharmaceuticals) for patients 1 year and older with relapsed or refractory ...

Rising greenhouse gases exacerbate cardiovascular mortality in older heart failure patients by increasing extreme temperatures. A U- or J-shaped relationship exists between nonoptimal temperatures and ...

Researchers have found that using mobile-app–based surveys and photography to remotely track and assess atopic dermatitis (AD ...